Mackaness James H
CHIEF FINANCIAL OFFICER at SOLENO THERAPEUTICS INC; CFO and COO at IRIX
- Sold, on record
- $11.2M
- Dollars the filings state
- Form 4 sales
- 30
- Latest Mar 27, 2025
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- SOLENO THERAPEUTICS INCCHIEF FINANCIAL OFFICER
- IRIXIRIDEX CORPCFO and COO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- SOLENO THERAPEUTICS INC192,201 shares
- IRIX121,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale SOLENO THERAPEUTICS INCUnusualDec 11 2023
Sold 32,482 shares at $36.41 ($1.2M)
Mackaness James H, Chief Financial Officer
No 10b5-1 planSold 72.8% of holdings ($1.6M position)12,128 shares leftFollows a Form 144Filing
- 2 Form 4 sale SOLENO THERAPEUTICS INCNo planApr 1 +112 days
Sold 5,175 shares at $41.34 ($214k)
Mackaness James H, CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 7.6% of holdings ($2.8M position)62,953 shares left0.6x usual sizeFiling
- 3 Form 4 sale SOLENO THERAPEUTICS INCNo planJul 1 +91 days
Sold 7,190 shares at $41.54 ($299k)
Mackaness James H, CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 11.4% of holdings ($2.6M position)55,763 shares left1.1x usual sizeFiling
- 4 Form 4 sale SOLENO THERAPEUTICS INCNo planAug 6 +36 days
Sold 14,983 shares at $45.60 ($683k)
Mackaness James H, CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 9.6% of holdings ($7.1M position)140,780 shares left2.1x usual sizeFiling
- 5 Form 4 sale SOLENO THERAPEUTICS INCNo planAug 29 +23 days
Sold 13,531 shares at $47.43 ($642k)
Mackaness James H, CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 9.6% of holdings ($6.7M position)127,249 shares left1.8x usual sizeFiling
- 6 Form 4 sale SOLENO THERAPEUTICS INCNo planOct 1 +33 days
Sold 8,077 shares at $49.43 ($399k)
Mackaness James H, CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 6.3% of holdings ($6.3M position)119,172 shares left1x usual sizeFiling
- 7 Form 4 sale SOLENO THERAPEUTICS INCNo planJan 3 +94 days
Sold 7,874 shares at $45.78 ($360k)
Mackaness James H, CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 6.6% of holdings ($5.5M position)111,298 shares left1x usual sizeFiling
- 8 Form 4 sale SOLENO THERAPEUTICS INCUnusualMar 27 +83 days
Sold 90,622 shares at $69.45 ($6.3M)
Mackaness James H, CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 46.3% of holdings ($13.6M position)105,176 shares left11.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (31)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | SOLENO THERAPEUTICS INC | CHIEF FINANCIAL OFFICER | Form 4 sale | 90,622 | $6.3M | 46.3% | Unusual | SEC |
| Jan 3, 2025 | SOLENO THERAPEUTICS INC | CHIEF FINANCIAL OFFICER | Form 4 sale | 7,874 | $360k | 6.6% | No plan | SEC |
| Oct 1, 2024 | SOLENO THERAPEUTICS INC | CHIEF FINANCIAL OFFICER | Form 4 sale | 8,077 | $399k | 6.3% | No plan | SEC |
| Aug 29, 2024 | SOLENO THERAPEUTICS INC | CHIEF FINANCIAL OFFICER | Form 4 sale | 13,531 | $642k | 9.6% | No plan | SEC |
| Aug 6, 2024 | SOLENO THERAPEUTICS INC | CHIEF FINANCIAL OFFICER | Form 4 sale | 14,983 | $683k | 9.6% | No plan | SEC |
| Jul 1, 2024 | SOLENO THERAPEUTICS INC | CHIEF FINANCIAL OFFICER | Form 4 sale | 7,190 | $299k | 11.4% | No plan | SEC |
| Apr 1, 2024 | SOLENO THERAPEUTICS INC | CHIEF FINANCIAL OFFICER | Form 4 sale | 5,175 | $214k | 7.6% | No plan | SEC |
| Dec 11, 2023 | SOLENO THERAPEUTICS INC | Chief Financial Officer | Form 4 sale | 32,482 | $1.2M | 72.8% | Unusual | SEC |
| Dec 11, 2023 | SOLENO THERAPEUTICS INC | Officer | Form 144 notice | 32,482 | $1.2M | Notice | SEC | |
| Nov 30, 2023 | SOLENO THERAPEUTICS INC | Chief Financial Officer | Form 4 sale | 4,186 | $120k | 16.4% | No plan | SEC |
| Nov 29, 2023 | SOLENO THERAPEUTICS INC | Chief Financial Officer | Form 4 sale | 8,081 | $222k | 24.1% | No plan | SEC |
| Aug 19, 2015 | IRIX | CFO and COO | Form 4 sale | 2,373 | $17k | 5.0% | Plan not stated | SEC |
| Aug 18, 2015 | IRIX | CFO and COO | Form 4 sale | 4,862 | $34k | 9.8% | Plan not stated | SEC |
| Aug 14, 2015 | IRIX | CFO and COO | Form 4 sale | 7,765 | $54k | 15.1% | Plan not stated | SEC |
| May 20, 2015 | IRIX | CFO and COO | Form 4 sale | 2,000 | $20k | 4.5% | Plan not stated | SEC |
| Jul 21, 2014 | IRIX | CFO and COO | Form 4 sale | 1,000 | $8k | 33.3% | Unusual | SEC |
| Jun 23, 2014 | IRIX | CFO and COO | Form 4 sale | 2,000 | $16k | 50.0% | Unusual | SEC |
| May 21, 2014 | IRIX | CFO and COO | Form 4 sale | 3,000 | $26k | 60.0% | Unusual | SEC |
| Apr 22, 2014 | IRIX | CFO and COO | Form 4 sale | 4,000 | $35k | 66.7% | Unusual | SEC |
| Mar 21, 2014 | IRIX | CFO and COO | Form 4 sale | 4,000 | $36k | 66.7% | Unusual | SEC |
| Dec 2, 2013 | IRIX | CFO and COO | Form 4 sale | 10,000 | $105k | 100.0% | Unusual | SEC |
| Nov 6, 2013 | IRIX | CFO and COO | Form 4 sale | 10,000 | $84k | 40.0% | Unusual | SEC |
| Jun 18, 2013 | IRIX | CFO and COO | Form 4 sale | 19,862 | $91k | 57.0% | Unusual | SEC |
| Jun 17, 2013 | IRIX | CFO and COO | Form 4 sale | 10,568 | $57k | 36.2% | Unusual | SEC |
| Jun 13, 2013 | IRIX | CFO and COO | Form 4 sale | 1,400 | $7k | 3.1% | Plan not stated | SEC |
| Jun 11, 2013 | IRIX | CFO and COO | Form 4 sale | 1,200 | $7k | 2.6% | Plan not stated | SEC |
| Jun 10, 2013 | IRIX | CFO and COO | Form 4 sale | 6,970 | $37k | 23.9% | Plan not stated | SEC |
| Feb 19, 2013 | IRIX | CFO and COO | Form 4 sale | 6,000 | $27k | 75.0% | Unusual | SEC |
| Feb 14, 2013 | IRIX | CFO and COO | Form 4 sale | 9,000 | $43k | 81.8% | Unusual | SEC |
| Feb 11, 2013 | IRIX | CFO & COO | Form 4 sale | 6,000 | $28k | 75.0% | Unusual | SEC |
| Feb 7, 2013 | IRIX | Chief Financial Officer | Form 4 sale | 9,000 | $42k | 81.8% | Unusual | SEC |